OTCM
ETTYF
Market cap18bUSD
, Last price
Name
Essity AB (publ)
Chart & performance
P/E
—
P/S
—
EPS
18.78
Vol. 1Y
—
Shs. 5Y
-0.38%
Rev. 5Y
2.61%
Div Yld LY
—
Div Yld TTM
—
Revenues
138.49b
-4.85%
Net income
12.66b
-39.41%
CFO
15.46b
-7.99%
Dividend
Mar 27, 20260.96863 /sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Essity AB engages in the development, production, and marketing of personal care products. It operates through the following segments: Personal Care, Consumer Tissue, Professional Hygiene, and Other Operations. The Personal Care segment offers incontinence products, baby care, feminine care, and medical solutions. The Consumer Tissue segment consists of toilet paper, household towels, handkerchiefs, facial tissues, wet wipes, and napkins. The Professional Hygiene segment comprises complete hygiene solutions, including toilet paper, paper hand towels, napkins, hand soap, hand lotion, hand sanitizers, dispensers, cleaning and wiping products, internet of things sensor technology, and service and maintenance. The Other Operations segment refers to the group-wide functions. The company was founded in 1929 and is headquartered in Stockholm, Sweden.
Related entities
Subsidiaries (83)
BSN MEDICAL (AUST.) PTY LTD
BSN medical GmbH
BSN Medical Inc.
BSN MEDICAL INTELLECTUAL PROPERTY MANAGEMENT C.V.
BSN MEDICAL LIMITED
BSN MEDICAL SAS
BSN-Jobst GmbH
ESSITY ALPHABET HOLDING B.V.
ESSITY AUSTRALASIA PTY LTD
ESSITY BELGIUM
ESSITY CANADA INC.
ESSITY CAPITAL B.V.
Essity Czech Republic s.r.o.
Essity Denmark A/S
ESSITY DISTRIBUTION B.V.
ESSITY DO BRASIL INDUSTRIA E COMERCIO LTDA
Essity Forsakringsaktiebolag
Essity Germany GmbH
Essity GmbH
Essity Group Holding B.V.
Key people
President, Chief Executive Officer · since 2025
Anand Chandarana
President - Health & Medical · since 2026
Pablo Fuentes
President - Professional Hygiene · since 2022
Donato Giorgio
President - Global Supply Chain · since 2021
Andres Gomez
President - Consumer Goods Americas · since 2021
Tuomas Yrjoelae
President - Global Marketing & Innovation · since 2025
Volker Zoller
President - Consumer Tissue · since 2026
Anna Aslund
Chief Human Resources Officer, Group Function Human Resources · since 2023
Fredrik Rystedt
Chief Financial Officer, Executive Vice President, Head - Group Function Finance · since 2017
Carl-Magnus Mansson
Chief Digital and Information Officer, Global Digital and Business Services · since 2023
Mikael Schmidt
Chief Group Function Legal Affairs and Compliance, General Counsel, Secretary to the Board · since 2023
Jessica Alm
Chief Communication Officer, Group Function Communications · since 2023
Sahil Tesfu
Chief Strategy Officer, Group Function Strategy & Sustainability · since 2025
Director · since 2024
Sofia Lafqvist
Director, Employee Representative · since 2024
Susanna Naumanen
Director, Employee Representative · since 2019
Orjan Svensson
Director, Employee Representative · since 2017
Independent Director · since 2016
Maria Carell
Independent Director · since 2023
Independent Director · since 2016
Legal address
Box 200
STOCKHOLM, AB 101 23
SE
STOCKHOLM, AB 101 23
SE
Headquarters
Klarabergsviadukten 63
Stockholm, AB 111 64
SE
Stockholm, AB 111 64
SE
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||